Focalyx vs Nyushko prostate nomograms

Application tailored to monitor diagnostic and treatment characteristics of men diagnosed with prostate cancer. It provides direct interaction between patients and physicians across our Focalyx network. It also allows the general public to use it as a health record and obtain resources and guidance in disruptive technologies aimed to preserve quality of life while dealing with prostate cancer

This app is intended to assess the risks of prostate cancer (PC) progression after surgical treatment in patients with localized and locally advanced processes. Based on a comprehensive analysis of pre- and postoperative prognostic factors, this application allows to assess and predict the risks of biochemical progression of the disease and use the result to plan subsequent adjuvant therapy in a cohort of patients with high risk of progression after surgery. Also, using the application, it is possible to predict the probability of lymph node metastases, the probability of extracapsulare extension and the probability of seminal vesicle invasion. For patients: This application does not provide a diagnosis; it only predicts the risk of prostate cancer progression. We do not recommend taking any medications. We are not responsible for the misuse of our application. If you are not a doctor, consult a specialist for interpretation of the results obtained, as well as possible correction of treatment. For specialists (oncologist, urologist): Using this application, you can predict the risk of prostate cancer progression with high accuracy, which will allow you to develop further tactics for managing your patients - the result obtained can be used to prescribe further adjuvant therapy or keep the patient under active supervision. The calculation of nomograms in the application is carried out by monthly subscription!